Clik here to view.
Condom Vending Machines Set Up at NCKU
TAINAN, Taiwan National Cheng Kung University (NCKU), southern Taiwan, implementing two condom vending machines, June 27, on campus makes it the first national university in Taiwan to promote safe...
View ArticleClik here to view.
Promega 2012 Corporate Responsibility Achievements Continue to Benefit...
Smart Multimedia Gallery Promega 2012 Corporate Responsibility Achievements Continue to Benefit Environment and Community View and Share Photo Download Small MADISON, Wis. The recently released...
View ArticleClik here to view.
Transgene Grants Ascend Biopharmaceuticals a License to TG1042, an...
STRASBOURG, France Regulatory News: Transgene SA (Paris:TNG) (Euronext Paris: TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in...
View ArticleClik here to view.
SK Biopharmaceuticals and AriBio Enter into a Strategic Alliance
SEOUL, Korea The Korea-based international pharmaceutical company, SK Biopharmaceuticals, and the Korea-based emerging biotech, AriBio, announced that they entered into a collaboration agreement for...
View ArticleClik here to view.
マリンクロット、第3四半期業績を2013年8月9日に発表
ダブリン （ビジネスワイヤ） — マリンクロット（NYSE: MNK）は、第3四半期業績を2013年8月9日のニューヨーク証券取引所開場前に発表します。投資家向け電話会議は、米国東部夏時間午前8時30分から開催します。電話会議には3つの方法で参加可能です。 マリンクロットのウェブサイト：http://mallinckrodt.com/investor_relations.aspx...
View ArticleClik here to view.
Otsuka Europe Development and Commercialisation Ltd., a New Company for the...
TOKYO & UXBRIDGE, United Kingdom Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the formation of Otsuka Europe Development and Commercialisation Ltd. (OEDC). Established on July 1st,...
View ArticleClik here to view.
Mallinckrodt plc将于2013年8月9日公布第三季度业绩
都柏林 (美国商业资讯)–Mallinckrodt plc (NYSE: MNK)将于2013年8月9日纽约证券交易所开市之前公布第三季度业绩。该公司将从美国东部夏令时间上午8:30开始举行投资者电话会议。共有三种方法参加此次电话会议。 登录Mallinckrodt网站：http://mallinckrodt.com/investor_relations.aspx...
View ArticleClik here to view.
KCI推出简化表皮提取的新型工具
圣安东尼奥 (美国商业资讯)–Kinetic Concepts, Inc.(KCI)今日宣布，其CelluTome™表皮提取系统现已在美国市售。CelluTome™表皮提取系统提供自动、精确且可重复的自体无损表皮组织提取步骤。该新系统的简便性使得比以往广泛得多的医生和患者能够获得植皮的疗效。 迈阿密大学米勒医学院皮肤病及皮肤外科副主任、教授Robert Kirsner, MD,...
View ArticleClik here to view.
BioAlliance Pharma Expands and Strengthens Its Industrial Property Assets...
PARIS Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company dedicated to the development of orphan oncology products and supportive care products, announces it was granted two...
View ArticleClik here to view.
KCIが表皮採取を簡素化する新規ツールを発売
サンアントニオ （ビジネスワイヤ） — キネティック・コンセプツは本日、表皮採取システムCelluTome™の発売を米国で開始したと発表しました。表皮採取システムCelluTome™は無損傷の自己表皮組織を採取するための精密で再現性のある自動化プロセスを提供します。この新システムは簡素であるため、これまでよりはるかに多くの医師や患者が表皮移植の恩恵を受けることが可能となります。...
View ArticleClik here to view.
SpinalCyte, LLC Receives Japanese Patent for Spinal Disc Tissue Engineering
HOUSTON SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the Japan Patent Office issued a...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Decitabine for Injection
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of Dacogen® (Decitabine for...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
HYDERABAD, India Dr. Reddy’s Laboratories Limited (NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended...
View ArticleClik here to view.
C2N Diagnostics Announces Collaborative Research and Global Exclusive...
ST. LOUIS C2N Diagnostics (C2N) today announced that it has signed a collaborative research and a global, exclusive supplier agreement with Cambridge Isotope Laboratories, Inc (CIL). The partnership...
View ArticleClik here to view.
Hundreds of millions of vulnerable Indian citizens lack free access to...
LONDON Modern India has the third largest national economy in the world in purchasing power adjusted terms. The country is also now the world’s largest generic medicines exporter. But 400-600...
View ArticleClik here to view.
Phase II Clinical Data Show Statistically Significant Improvement for Lu...
BOSTON H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the presentation of the first clinical data on the investigational drug Lu AE58054 in Alzheimer’s...
View ArticleClik here to view.
Phase II Clinical Data Show Statistically Significant Improvement for Lu...
BOSTON H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the presentation of the first clinical data on the investigational drug Lu AE58054 in Alzheimer’s...
View ArticleClik here to view.
大塚製薬とルンドベック社：Lu AE58054の臨床第II相試験においてアルツハイマー型認知症治療に有効性...
東京 （ビジネスワイヤ） — 大塚製薬株式会社（本社：東京都千代田区、代表取締役社長：岩本太郎、以下「大塚製薬」）とH.ルンドベックA/S（本社：デンマーク、コペンハーゲン、CEO:ウルフ・ウインバーグ、以下「ルンドベック社」）は、開発中のアルツハイマー病治療薬Lu AE58054の臨床試験データを、ボストンで開催されたアルツハイマー病協会国際会議（AAIC...
View ArticleClik here to view.
II期临床数据显示，选择性5-HT6受体拮抗剂Lu AE58054联合多奈哌齐对阿尔茨海默病认知症状的改善效果有统计学意义...
丹麦VALBY和东京 (美国商业资讯)–丹麦灵北制药公司（H. Lundbeck A/S，以下简称“灵北”）和大冢制药株式会社（以下简称“大冢”）今天在波士顿召开的阿尔茨海默病协会2013年国际会议(AAIC 2013)上发布了研究药物Lu AE58054治疗阿尔茨海默病的首批临床数据。 该项II期临床研究显示，在多奈哌齐基础上添加Lu...
View ArticleClik here to view.
GE医疗集团宣布其层析X线乳房成像组合解决方案SenoClaire获得认证
法国BUC (美国商业资讯) — GE医疗集团(NYSE: GE)今天宣布，该公司配置了三维成像技术的新一代层析X线乳房成像组合解决方案SenoClaire*获得CE认证，以此开创了乳房成像的新纪元。SenoClaire技术由ASiR*DBT 1驱动，采用低剂量短程X射线，在定位后的乳房周围以“步进照相”法扫描，曝光9次，消除了可能的图像抖动。...
View Article